Most people in the U.S. have received vaccines to protect against infectious diseases. A vaccine against smallpox led to the ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell lung cancer ... s major successes: mRNA vaccines. As COVID-19 spread across the U.S. in 2020 ...

Non-small-cell lung cancer. Various adjuvant products are currently under evaluation as potential candidates for use in cancer vaccines. There are several anticancer developmental vaccines ...

2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive ... Experimental mRNA Cancer Vaccine Shows ...

It is currently being tested in a phase two lung cancer study and a breast cancer study. Another project focuses on a colon cancer vaccine that targets pre-cancerous lesions called colon adenomas.

PGV001, a personalized multi-peptide neoantigen cancer vaccine, induced a strong immune response in patients with non-small cell lung cancer, head and neck cancer, urothelial cancer, breast cancer and ...

such as melanoma and lung cancer. Results from the Phase 2b KEYNOTE-942 study demonstrated the potential of combining mRNA-4157 (V940), an mRNA-based cancer vaccine with the checkpoint inhibitors ...

EVM14 is an off-the-shelf mRNA mRNA cancer vaccine targeting multiple tumor-associated antigens, which is designed to treat various cancers, including non-small cell lung cancer and head and neck ...